Login to Your Account



It Was a Grueling Day for Biotechnology Stocks


Friday, August 5, 2011
Amid the overall U.S. market plunge tipped by economic uncertainty on Thursday, the biotech sector suffered an additional gut check on the heels of Dendreon Corp.'s second quarter miss.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription